Krystal Biotech, Inc. Common Stock (KRYS) Ownership & Trading Activity
Institutional holders, insider transactions, and congressional trades for KRYS. 13F holdings as of 2026-06-30.
In 13F filings for the quarter ended June 30, 2026, 411 institutions reported holding KRYS, with 30.3 million shares worth $11.1 billion in aggregate.
Top Institutional Holders
| Institution | Shares | Value | Change |
|---|---|---|---|
| FMR | 4,418,197 | $1.6B | INCREASED |
| BlackRock | 4,181,432 | $1.6B | INCREASED |
| Vanguard | 3,047,073 | $1.1B | INCREASED |
| Avoro Capital Advisors | 2,888,888 | $1.1B | UNCHANGED |
| State Street | 1,351,158 | $502M | INCREASED |
Recent Insider Trades
| Insider | Type | Shares | Value | Date |
|---|---|---|---|---|
| Catherine Mazzacco (Director) | AWARD | 471 | 2026-09-14 | |
| Catherine Mazzacco (Director) | AWARD | 1,187 | $404K | 2026-09-14 |
| Everett Rand Sutherland (Director) | AWARD | 471 | 2026-09-14 | |
| Everett Rand Sutherland (Director) | AWARD | 1,187 | $404K | 2026-09-14 |
| Christopher Mason (Director) | AWARD | 471 | 2026-09-14 |
Full institutional holdings, insider history, and congressional trades for Krystal Biotech, Inc. Common Stock on SentiSense.